Krystal Biotech Inc banner

Krystal Biotech Inc
NASDAQ:KRYS

Watchlist Manager
Krystal Biotech Inc Logo
Krystal Biotech Inc
NASDAQ:KRYS
Watchlist
Price: 261.08 USD 0.94% Market Closed
Market Cap: $7.6B

Wall Street
Price Targets

KRYS Price Targets Summary
Krystal Biotech Inc

Wall Street analysts forecast KRYS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KRYS is 313.24 USD with a low forecast of 217.15 USD and a high forecast of 389.55 USD.

Lowest
Price Target
217.15 USD
17% Downside
Average
Price Target
313.24 USD
20% Upside
Highest
Price Target
389.55 USD
49% Upside
Krystal Biotech Inc Competitors:
Price Targets
OFIX
Orthofix Medical Inc
48% Upside
BTBT
Bit Digital Inc
234% Upside
PTEN
Patterson-UTI Energy Inc
-6% Downside
PWP
Perella Weinberg Partners
55% Upside
KRNY
Kearny Financial Corp
23% Upside

Revenue
Forecast

N/A
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

The compound annual growth rate of Krystal Biotech Inc's revenue for the next 3 years is 36%.

Operating Income
Forecast

N/A
Past Growth
47% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
47% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

The compound annual growth rate of Krystal Biotech Inc's operating income for the next 3 years is 47%.

Net Income
Forecast

N/A
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
-29%
Average Miss
N/A
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
-29%
Average Miss

The compound annual growth rate of Krystal Biotech Inc's net income for the next 3 years is 29%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is KRYS's stock price target?
Price Target
313.24 USD

According to Wall Street analysts, the average 1-year price target for KRYS is 313.24 USD with a low forecast of 217.15 USD and a high forecast of 389.55 USD.

What is Krystal Biotech Inc's Revenue forecast?
Projected CAGR
36%

The compound annual growth rate of Krystal Biotech Inc's revenue for the next 3 years is 36%.

What is Krystal Biotech Inc's Operating Income forecast?
Projected CAGR
47%

The compound annual growth rate of Krystal Biotech Inc's operating income for the next 3 years is 47%.

What is Krystal Biotech Inc's Net Income forecast?
Projected CAGR
29%

The compound annual growth rate of Krystal Biotech Inc's net income for the next 3 years is 29%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett